Using Hormone Therapy To Prevent Chronic Health Issues In Postmenopausal Women May Do More Harm Than Good

reports that “harms far outweighed the benefits,” the panel found. The draft recommendation’s authors “found ‘convincing evidence’ that combined therapy was linked with’ moderate benefit’ in reducing the risk of fractures and ‘adequate evidence’ that it was associated with a ‘small benefit’ in reducing the risk of diabetes.” The USPSTF panelists, however, “found ‘convincing evidence’ that combined use of estrogen and progestin was linked with ‘moderate harms,’ such as increased risk of invasive breast cancer and venous thromboembolism, and small to moderate harms of heightened risk for coronary heart disease.” http://www.medpagetoday.com/obgyn/menopause/65341